Target intelligence / Profile preview

23S ribosomal RNA on 50S ribosomal subunit (23S rRNA)

Target
23S rRNA
Molecular classification
Ribosomal RNA, Non-coding RNA, Structural RNA, Component of ribosome (50S ribosomal subunit)
01

Overview

23S ribosomal RNA (23S rRNA) is a large (2,904 nucleotides in E. coli) non-coding RNA that forms the core structural and functional framework of the 50S large ribosomal subunit in bacteria and archaea. It consists of six structural domains and plays the central catalytic role in the peptidyl transferase center (PTC), facilitating the formation of peptide bonds during protein synthesis[3][6]. The 23S rRNA also provides essential tRNA binding sites and serves as the main binding target for several classes of antibiotics, which act by inhibiting bacterial translation. Mutations in domains of this rRNA are linked to drug resistance and can affect cell growth and ribosome assembly[3][1][4][6]. The bacterial 23S rRNA is phylogenetically distinct and highly conserved among prokaryotes, with its eukaryotic counterpart being the 28S rRNA[3]. Note: The 23S rRNA itself is not a protein, receptor, or enzyme but a fundamental ribonucleic acid molecule with direct catalytic activity and binding properties for both functional (protein synthesis) and therapeutic (antibiotic interaction) applications[3][2][1].

Other names
23S RNA23S rRNAlarge subunit ribosomal RNApeptidyl transferase RNAbacterial 23S rRNA
02

Mechanism of action

Antibiotics bind to 23S rRNA (often domain V in the peptidyl transferase center), inhibiting peptide bond formation and blocking protein synthesis. This leads to bacterial cell death or stasis

03

Biological functions

Protein synthesis (translation)Peptidyl transferase activity (catalysis of peptide bond formation)Structural scaffold for ribosomal assemblyBinding to transfer RNA (tRNA) during translation
04

Disease associations

Infection (major target for antibiotics, implication in antibiotic resistance)
05

Safety considerations

Selectivity: drugs targeting bacterial 23S rRNA should ideally not affect the eukaryotic homolog (28S rRNA) to avoid off-target toxicityEmergence of resistance: point mutations in 23S rRNA that confer drug resistance pose a major challenge
06

Interacting drugs

Chloramphenicol

4 more in the full profile.

07

Biomarkers

Mutations in 23S rRNA associated with antibiotic resistance (e.g., specific point mutations conferring resistance to macrolides or oxazolidinones)

Beyond the preview

Go deeper on 23S ribosomal RNA on 50S ribosomal subunit (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA on 50S ribosomal subunit (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call